Patent ID: 8486967

Claim:
A compound of formula I wherein hetaryl I is 1,2,4-thiadiazole; hetaryl II is a [1,2,4]triazolo1,5-a]pyridine ring or a 5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridine ring; R 1 is lower alkyl, lower alkoxy, lower alkyl substituted by halogen, or halogen; R 2 is halogen, lower alkyl, lower alkoxy, hydroxy, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy or benzo[1,3]dioxolyl, or is —(CHR) p -phenyl, optionally substituted by halogen, lower alkyl, lower alkoxy, S(O) 2 -lower alkyl, cyano, nitro, lower alkoxy substituted by halogen, dimethylamino, —(CH 2 )p-NHC(O)O-lower alkyl, or lower alkyl substituted by halogen, R is hydrogen, halogen, hydroxy or lower alkoxy, or is cycloalkenyl or cycloalkyl, each of which is optionally substituted by hydroxy or lower alkyl substituted by halogen, or is a five or six membered heteroaryl group, containing 1 to 3 heteroatoms, selected from O, S and N, which is optionally substituted by halogen, lower alkyl, lower alkoxy or dimethylamino, or is O-phenyl, optionally substituted by halogen, or is heterocycloalkyl, optionally substituted by halogen, hydroxy, lower alkyl substituted by halogen or C(O)O-lower alkyl; R 3 is hydrogen, lower alkyl, cyano or phenyl; R 4 is lower alkoxy, lower alkyl or halogen; p is 0 or 1; n is 0, 1 or 2; when n is 2 then each R 4 is the same or different; m is 0, 1 or 2; when m is 2 then each R 1 is the same or different; o is 0, 1, 2 or 3, when o is 2 or 3 then each R 2 is the same or different; or a pharmaceutically active acid addition salt thereof.